Company Filing History:
Years Active: 2012-2013
Title: Gerald Bacher: Innovator in Therapeutic Peptides
Introduction
Gerald Bacher is a notable inventor based in Germering, Germany. He has made significant contributions to the field of therapeutic agents, particularly through his innovative peptide compounds. With a total of 6 patents, Bacher's work focuses on addressing various medical conditions, including cancer and autoimmune diseases.
Latest Patents
Bacher's latest patents include the use of octreotide as a therapeutic agent. This invention is directed towards the peptide compound D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol, which is utilized for the prophylaxis and treatment of a range of diseases, such as cancer, fibrotic diseases, and neurodegenerative diseases. Additionally, he has developed a patent for the use of Gonadorelin as a therapeutic agent, involving the peptide compound Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2. This compound also targets similar medical conditions and is formulated in various pharmaceutical compositions.
Career Highlights
Throughout his career, Gerald Bacher has worked with companies such as Mondobiotech Laboratories AG and Mondobiotech AG. His experience in these organizations has contributed to his expertise in the development of therapeutic peptides.
Collaborations
Bacher has collaborated with notable individuals in his field, including Dorian Bevec and Fabio Cavalli. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
Gerald Bacher's contributions to the field of therapeutic agents through his innovative peptide compounds demonstrate his commitment to advancing medical science. His patents reflect a dedication to addressing critical health issues, making him a significant figure in the realm of inventions.